These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18462339)

  • 21. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
    Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
    Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of contemporary devices used for transcatheter patent foramen ovale closure.
    Spies C; Reissmann U; Timmermanns I; Schräder R
    J Invasive Cardiol; 2008 Sep; 20(9):442-7. PubMed ID: 18762672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Percutaneous closure of patent foramen ovale: a wise approach].
    Gaspardone A; Iani C; Papa M
    G Ital Cardiol (Rome); 2008 Sep; 9(9):593-602. PubMed ID: 18783080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical embolism through the patent foramen ovale--the elderly is where the money is.
    Meier B
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):971-2. PubMed ID: 19021283
    [No Abstract]   [Full Text] [Related]  

  • 25. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials. A science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    J Am Coll Cardiol; 2009 May; 53(21):2014-8. PubMed ID: 19460622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    Circulation; 2009 May; 119(20):2743-7. PubMed ID: 19433754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patent foramen ovale and cryptogenic stroke.
    Silver B; Russman A
    N Engl J Med; 2008 Apr; 358(14):1519; author reply 1520-1. PubMed ID: 18389527
    [No Abstract]   [Full Text] [Related]  

  • 28. Implantation of a second Amplatzer device to eliminate residual shunt after transcatheter patent foramen ovale closure.
    Chessa M; Citro R; Butera G; Provenza G; Bossone E; Carminati M
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):736-7. PubMed ID: 19483639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous patent foramen ovale/atrial septal defect closure: just because we can?
    Opotowsky AR; Webb GD
    Ann Thorac Surg; 2009 Oct; 88(4):1386; author reply 1386-7. PubMed ID: 19766861
    [No Abstract]   [Full Text] [Related]  

  • 30. Patent foramen ovale and cryptogenic stroke.
    Kent DM; Trikalinos TA; Thaler DE
    N Engl J Med; 2008 Apr; 358(14):1519-20; author reply 1520-1. PubMed ID: 18389525
    [No Abstract]   [Full Text] [Related]  

  • 31. Right-to-left shunt through a patent foramen ovale left open in the management of acute right heart failure after heart transplantation.
    Ozdogan ME; Erer D; Iriz E; Oktar GL; Kula S; Buyukates M
    J Heart Lung Transplant; 2008 Jan; 27(1):135-7. PubMed ID: 18187100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A suture not always the ideal solution: problems encountered in developing a suture-based PFO closure technique.
    Majunke N; Baranowski A; Zimmermann W; Heinisch C; Wilson N; Robertson G; Wunderlich N; Sievert H
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):376-82. PubMed ID: 19085919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Foramen ovale: an alternative for left atrial access?
    Hu YF; Hsieh MH; Chen SA
    J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1242-4. PubMed ID: 18775039
    [No Abstract]   [Full Text] [Related]  

  • 34. Another addition to the tool box.
    Tuzcu EM
    Catheter Cardiovasc Interv; 2008 May; 71(6):829-30. PubMed ID: 18412080
    [No Abstract]   [Full Text] [Related]  

  • 35. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.
    Opotowsky AR; Landzberg MJ; Kimmel SE; Webb GD
    Am Heart J; 2009 May; 157(5):867-74. PubMed ID: 19376313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patent foramen ovale: clinical manifestations and treatment.
    Kedia G; Tobis J; Lee MS
    Rev Cardiovasc Med; 2008; 9(3):168-73. PubMed ID: 18953276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is closure of patent foramen ovale to prevent ischaemic stroke ever justified?
    Henderson RA; Bath PM
    BMJ; 2013 Oct; 347():f6193. PubMed ID: 24167203
    [No Abstract]   [Full Text] [Related]  

  • 38. Does closure of a patent foramen ovale have a role in the treatment of migraine with aura?
    D'Amico D; Usai S; Caputi L; Bussone G
    Neurol Sci; 2008 May; 29 Suppl 1():S23-7. PubMed ID: 18545890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Migraine Intervention With STARFlex Technology trial: a controversial trial of migraine and patent foramen ovale closure.
    Carroll JD
    Circulation; 2008 Mar; 117(11):1358-60. PubMed ID: 18332260
    [No Abstract]   [Full Text] [Related]  

  • 40. Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt.
    Weimar C; Holle DN; Benemann J; Schmid E; Schminke U; Haberl RL; Diener HC; Goertler M;
    Cerebrovasc Dis; 2009; 28(4):349-56. PubMed ID: 19628936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.